## **Core Concept**
The question tests knowledge of antipsychotic medications and their applications in managing conditions like Parkinson's disease. Specifically, it focuses on the use of antipsychotics in patients with Parkinson's disease, where managing psychosis or agitation is crucial. The ideal medication would have a favorable side effect profile, particularly concerning motor symptoms.

## **Why the Correct Answer is Right**
Clozapine is an atypical antipsychotic known for its efficacy in treatment-resistant schizophrenia. Importantly, it has a lower risk of causing extrapyramidal side effects (EPS), such as those seen in Parkinson's disease (e.g., tremors, rigidity). This characteristic makes Clozapine a suitable option for managing psychotic symptoms in Parkinsonian patients, who are particularly sensitive to EPS.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Typical antipsychotics (e.g., Haloperidol) are generally not preferred in Parkinsonian patients due to their high risk of inducing or worsening EPS.
- **Option B:** While some atypical antipsychotics are used off-label for managing psychosis in Parkinson's disease, not all are as favorable as Clozapine in terms of EPS risk. The specific pharmacological profile can vary.
- **Option D:** Quetiapine is another atypical antipsychotic used off-label for psychosis in Parkinson's disease. However, Clozapine's unique profile, with a very low risk of EPS and established efficacy, makes it particularly notable.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that Clozapine requires regular monitoring of white blood cell counts due to the risk of agranulocytosis, a potentially life-threatening side effect. This monitoring is a critical aspect of using Clozapine safely.

## **Correct Answer:** C. Clozapine